INDIANAPOLIS, IN – (July 14, 2014) – Zotec Partners, LLC (Zotec), a leading provider of billing and practice management services to hospital-based physicians, is pleased to announce that it has hired esteemed industry veteran Mark Scruggs, as a partner of corporate strategy.

ACA has accelerated the rate of change in healthcare and payors are under the gun to make the transition from an industry in which the customer is a corporation to one in which consumers call the shots. Many current market leaders could be unseated, predicts a June report from McKinsey & Company.

LOS ANGELES, July 8, 2014 (GLOBE NEWSWIRE) -- RadNet Inc.(Nasdaq:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 250 owned and/or operated outpatient imaging centers, announced it has joined a research study, the Imaging and Genetic Biomarkers for Alzheimer's Disease (ImaGene) study. The study is supported in part by GE Healthcare and sponsored by the Jim Easton Consortium for Alzheimer's Disease Drug Discovery and Biomarkers, and, the National Institute of Aging.

NEW YORK (July 1, 2014) — In response to a recent national study showing that CT scans in a select high-risk population lower lung cancer deaths, NewYork-Presbyterian/Weill Cornell Medical Center has launched a lung cancer screening program for those at risk for developing the disease. The program uses low-dose CT scans to detect cancer in its earliest stages, giving patients a significantly better chance to survive the disease. Lung cancer is the leading cause of cancer death for men and women in the United States and current data shows that most lung cancers are diagnosed at an advanced stage.

Scottsdale, Ariz., July 1, 2014 – PHS Technologies Group LLC, a unit of PACSHealth LLC and developer of software that monitors patient exposure to ionizing radiation, today announced that Dell Healthcare and Life Sciences will become a marketing, distribution and hosting partner for its DoseMonitor® OnLine software solution.

Columbia, MO, June 23, 2014 – Argus Radiology, a United States based and privately owned Teleradiology/Telemedicine healthcare service company, has been awarded The Joint Commission’s prestigious “Gold Seal of Approval®.” The internationally recognized symbol is granted as an indicator of Argus Radiology’s commitment to provide high quality patient care, improve efficiencies and meet the most rigorous standards of performance, as seen on argusrad.com/accreditation.

The Medical Group Management Association expresses its concern about the improper use of virtual credit cards and unreasonable fees charged by payors for electronic funds transfer in a letter addressed to CMS Administrator Marilyn Tavenner.

 FUJIFILM MEDICAL SYSTEMS U.S.A., INC. DEMONSTRATES LATEST INNOVATIONS IN ECHOCARDIOGRAPHY IMAGE MANAGEMENT AND REPORTING AT THE 25th ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY Stamford, Conn., June 19, 2014 (Booth #301) – FUJIFILM Medical Systems U.S.A., Inc. will demonstrate the next generation of Synapse Cardiovascular, that will allow cardiologists and clinical professionals to enhance patient care through advanced reporting applications  at the 25th Annual Scientific Session of the American Society of Echocardiography in Portland, Oregon. “With Synapse, our users are able to perform their job more efficiently and ultimately allow them to concentrate more on the patient and improve patient outcomes,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “At ASE, we will demonstrate an upcoming clinical reporting platform that will feature a new user interface and layout options that has the potential to benefit your entire practice.” Following is a summary of offerings:Synapse Cardiovascular helps cardiologists in a variety of clinical areas efficiently and confidently interpret images and compose structured reports with a streamlined workflow. The system has powerful capabilities designed specifically for, echocardiography, cardiac catheterization and invasive peripheral vascular, nuclear cardiology, vascular ultrasound, ECG management, CT, and Cardiac MRI workflows. Fujifilm's Synapse Cardiovascular is an essential addition to any clinical workplace.  At the show, attendees will also be able to see a works-in-progress demonstration of Synapse Cardiovascular 6.0*, which will showcase intended future functionality for echocardiography. Fujifilm will also share the benefits of its zero footprint mobile application, Synapse Mobility. The application enables access to Fujifilm’s suite of Synapse products from hand-held devices, in addition to browser independence. Access to non-DICOM information from the Synapse VNA has been added to complete the universal viewing capability from EMRs such as Epic Hyperspace.  Synapse Mobility continues to demonstrate its diagnostic capability for both browser and mobile versions. To register for a demonstration at ASE 2014, please visit: http://www.fujimed.com/gateway/ase/2014/registration.html.  *Synapse Cardiovascular 6.0 will be made commercially available in the U.S. upon receipt of FDA clearance For more information about Synapse, please visit: http://cardiovascular.fujimed.com/